DCF — PIEDMONT EASTSIDE MEDICAL CENTER
Enterprise Value: $-505.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-505.3M
Enterprise Value
$-157.3M
PV of Cash Flows
$-348.0M
PV of Terminal Value
$-560.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $240.6M | $-32.9M | -14.0% | $-43.1M | $-39.1M |
| Year 2 | $247.8M | $-31.4M | -13.0% | $-41.9M | $-34.6M |
| Year 3 | $255.3M | $-29.8M | -12.0% | $-40.6M | $-30.5M |
| Year 4 | $262.9M | $-29.3M | -11.0% | $-40.5M | $-27.6M |
| Year 5 | $270.8M | $-29.5M | -11.0% | $-41.0M | $-25.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-505.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$233.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1415945740074679
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5